Jacobsen syndrome is diagnosed through genetic testing that confirms a deletion on the long arm of chromosome 11, typically in the region known as 11q23 to 11q25. In most cases, doctors first suspect the condition based on a combination of physical features visible at birth, heart defects, and abnormally low platelet counts. Genetic testing then provides the definitive confirmation.
Signs That Raise Suspicion at Birth
Jacobsen syndrome is rare, so the diagnosis usually begins not with a genetic test but with a pediatrician or neonatologist noticing a pattern of features that don’t fit a more common condition. The combination that most strongly points toward Jacobsen syndrome is congenital heart disease alongside other physical abnormalities, particularly if the newborn also has thrombocytopenia (a low platelet count) or bruises and bleeds easily.
More than half of all children with Jacobsen syndrome have heart defects serious enough to need treatment or surgery. About two-thirds of those involve the left side of the heart, including holes between the ventricles, narrowing of the aorta, and underdevelopment of the left heart chambers. When a baby has one of these heart problems plus distinctive facial features, clinicians begin considering chromosomal causes.
The facial features associated with Jacobsen syndrome are often recognizable as a cluster: a skull shape that appears slightly unusual, small and low-set ears, widely spaced eyes, skin folds over the inner corners of the eyes, and downward-slanting eyelids. Not every child has all of these, but when several appear together alongside a heart defect or bleeding tendency, the pattern becomes suggestive. Growth delays and skeletal abnormalities may also be apparent early on.
The Role of Platelet Abnormalities
One of the most diagnostically useful clues is a specific type of platelet disorder called Paris-Trousseau syndrome, which occurs in nearly all children with deletions in the 11q23 region. Their platelets contain abnormally large storage granules (called giant alpha-granules) that can be seen under electron microscopy. The problem isn’t that the platelets die too quickly. Instead, the bone marrow produces them inefficiently, generating many undersized precursor cells that never mature properly.
A routine blood count showing low platelets in a newborn with heart defects and unusual facial features is often the trigger for genetic testing. If a blood smear or bone marrow examination reveals those characteristic giant granules and small precursor cells, the suspicion for Jacobsen syndrome becomes very strong even before chromosomal results come back.
Genetic Tests That Confirm the Diagnosis
The definitive diagnosis requires identifying the deleted segment of chromosome 11. Three main types of genetic testing can do this, and they differ in how much detail they provide.
- Karyotyping is the traditional approach. It produces an image of all 46 chromosomes and can detect large deletions. Because Jacobsen syndrome deletions are typically sizable (often 10 megabases or more), a standard karyotype can usually pick them up. This is often the first test ordered when a chromosomal disorder is suspected.
- FISH (fluorescence in situ hybridization) uses a fluorescent probe designed to bind to a specific region of chromosome 11. If the probe fails to light up one copy, it confirms a deletion in that area. FISH is useful for confirming a suspected deletion quickly or for testing family members.
- Chromosomal microarray analysis is the most detailed option. It scans the entire genome at high resolution and can pinpoint the exact size and boundaries of the deleted segment. This matters because the size of the deletion varies from person to person and correlates with which symptoms are more or less likely. Microarray has become the preferred first-line test in many genetics centers because it catches both large and small deletions in a single run.
In practice, a child presenting with the classic combination of features may receive a karyotype first, with microarray used to define the deletion more precisely. If the karyotype looks normal but suspicion remains high, microarray can detect smaller deletions that karyotyping would miss.
Prenatal Detection
Jacobsen syndrome can sometimes be identified before birth, though it is rarely the first diagnosis suspected during pregnancy. Certain findings on a routine prenatal ultrasound may prompt further investigation: a hole between the heart’s ventricles (ventricular septal defect), widening of the kidney’s drainage system, or the presence of a single umbilical artery instead of the usual two. None of these findings alone is specific to Jacobsen syndrome, but when they appear together, the combination is unusual enough to warrant genetic testing of the fetus.
Prenatal genetic testing can be done through amniocentesis or chorionic villus sampling. The collected fetal cells then undergo karyotyping or microarray analysis, the same tests used after birth. If a deletion on 11q is found, parents can begin planning with a medical team before delivery.
Evaluations After a Confirmed Diagnosis
Once genetic testing confirms Jacobsen syndrome, a thorough medical workup follows to identify which organ systems are affected in that particular child. Because the syndrome can impact the heart, brain, kidneys, eyes, ears, immune system, and hormonal regulation, the recommended evaluation is broad.
A pediatric cardiologist performs an EKG and echocardiogram to assess heart structure and function. A neurologist conducts a baseline evaluation and may order brain imaging, sometimes repeated over time to track development. An abdominal ultrasound checks for pyloric stenosis (a narrowing at the stomach outlet) and kidney or urinary tract malformations. Eye exams with pupil dilation look for coloboma and other structural issues, and hearing tests screen for auditory problems.
Blood work at this stage goes beyond a simple platelet count. It includes platelet function studies and bleeding time to characterize the severity of the bleeding risk. Hormone levels are checked, specifically growth factor (IGF-1) and thyroid-stimulating hormone (TSH), because growth delays and thyroid dysfunction are common. Immune function testing measures levels of the major antibody types (IgM, IgA, and IgG), since immunodeficiency affects a meaningful number of children with the syndrome and influences decisions about vaccinations and infection prevention.
This initial battery of tests creates a baseline. Because Jacobsen syndrome affects development over time, many of these evaluations are repeated at regular intervals throughout childhood. All children with the syndrome have some degree of intellectual disability, and developmental concerns like ADHD, autism spectrum traits, or behavioral challenges often become more apparent as the child grows, requiring ongoing neurological and developmental assessment.
Why Deletion Size Matters
Not every child with Jacobsen syndrome has the same deletion. The missing segment can range from a few megabases to more than 15 megabases, and larger deletions generally remove more genes and lead to more severe or widespread symptoms. This is why microarray testing, which maps the precise boundaries of the deletion, is so valuable. Knowing exactly which genes are missing helps the medical team anticipate which complications are most likely and tailor the follow-up plan accordingly. It also provides important information for genetic counseling, since in a small percentage of cases a parent carries a chromosomal rearrangement that increases the chance of recurrence in future pregnancies.